Astera Labs (NASDAQ:ALAB) Stock Price Up 9.4% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price rose 9.4% on Friday . The company traded as high as $182.52 and last traded at $182.0110. Approximately 817,110 shares changed hands during trading, a decline of 81% from the average daily volume of 4,207,079 shares. The stock had previously closed at $166.36.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ALAB shares. Barclays reissued an “equal weight” rating and issued a $155.00 price objective on shares of Astera Labs in a research note on Monday, October 20th. Roth Capital upped their target price on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Bank of America started coverage on shares of Astera Labs in a research note on Friday, October 3rd. They issued a “neutral” rating and a $230.00 target price for the company. Finally, BNP Paribas started coverage on shares of Astera Labs in a report on Thursday, November 20th. They set an “outperform” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $188.17.

Astera Labs Stock Performance

The company has a market cap of $30.11 billion, a price-to-earnings ratio of 160.58, a PEG ratio of 3.10 and a beta of 1.50. The firm’s 50-day moving average price is $160.60 and its 200 day moving average price is $159.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s revenue was up 103.9% on a year-over-year basis. During the same period last year, the company earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 4,620 shares of the firm’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the sale, the general counsel owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. This trade represents a 3.05% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the transaction, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at $301,015,680.42. This represents a 4.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 576,936 shares of company stock worth $87,409,540 over the last 90 days. 12.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after acquiring an additional 2,751,747 shares in the last quarter. Amundi lifted its holdings in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares in the last quarter. FengHe Fund Management Pte. Ltd. bought a new stake in shares of Astera Labs in the second quarter valued at about $106,772,000. Rafferty Asset Management LLC acquired a new position in shares of Astera Labs during the third quarter worth about $209,599,000. Finally, BNP Paribas Financial Markets grew its holdings in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.